Amoxicillin

CHEMBL1082 Phase 4 Aprobado Small molecule
Half-Life
1-1.5 hours
Bioavailability
Protein Binding
Molecular Weight
365.4 g/mol
LogP
-2.0
Phase
4

A broad-spectrum penicillin-type antibiotic that works by interfering with bacteria's ability to build their cell walls, causing them to burst and die. It is one of the most widely prescribed antibiotics for respiratory, ear, and urinary tract infections.

Peso molecular

365,4050 g/mol

LogP

-2,00

TPSA

158,00 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Clases de fármacos

Mecanismo de acción

Inhibits bacterial cell wall synthesis by binding to PBPs.

Pharmacokinetics (PK)

Half-Life 1-1.5 hours

Pharmacodynamics (PD)

Mecanismo

Inhibits bacterial cell wall synthesis by binding to PBPs.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O

InChI

InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1

Molecular Formula

C16H19N3O5S

HBD / HBA

4 / 7

Enlaces Rotables

4

Átomos Pesados

25

Primary Target

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A broad-spectrum penicillin-type antibiotic that works by interfering with bacteria's ability to build their cell walls, causing them to burst and die. It is one of the most widely prescribed antibiotics for respiratory, ear, and urinary tract infections.

Inhibits bacterial cell wall synthesis by binding to PBPs.

Key pharmacokinetic parameters for Amoxicillin: Half-life: 1-1.5 hours.

Yes, Amoxicillin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1082. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 33613. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.